Highlights
NASDAQ: IDXG       Interpace Diag Group
Last Price Today's Change   Day's Range   Trading Volume
4.257   -0.093 (2.14%)  3.90 - 4.48  42,245

Overview

 
Avg Volume (4 weeks):146,947
4 Weeks Range:3.05 - 4.70
4 Weeks Price Volatility (%):
73.15%
52 Weeks Range:2.57 - 11.00
52 Weeks Price Volatility (%):
20.01%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Interpace Diagnostics Group Inc is engaged in developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for patient diagnosis and management. The company currently has three commercialized molecular tests PancraGen for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts, ThyGenX, for the diagnosis of thyroid cancer from thyroid nodules utilizing a next generation sequencing assay and, ThyraMIR for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1991  4379  278  3253 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NAKD 0.495+0.059 
 F 11.665+0.805 
 ACST 0.848+0.092 
 BBIG 6.35+4.81 
 LK 1.38+1.38 
 CLSN 1.64+0.365 
 CTRM 0.352+0.027 
 WPX 9.43+0.48 
 ADTX 4.98+2.37 
 SNDL 0.657-0.023